Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: A literature review

World Journal of Gastroenterology

Volumn 19, Issue 3, 2013, Pages 321-327

  Su, Jiann Sheng ^a   Chen, Yu Tso ^b   Wang, Ren Ching ^b   Wu, Chun Ying ^b   Lee, Shou Wu ^b,c   Lee, Teng Yu ^b,d  

^a KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alpha fetoprotein; Alpha fetoprotein producing tumor; Gastric adenocarcinoma; Hepatocellular carcinoma; Pathology

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN AE1; CYTOKERATIN AE3; GLYPICAN 3; MUCIN 1; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER;

ADENOCARCINOMA; CELL PROLIFERATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEPATOID ADENOCARCINOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL;

EID: 84873731368     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i3.321     Document Type: Review

References (36)

1. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. [Existence of alpha feto protein during gastric-origin secondary cancer of the liver]. Presse Med 1970; 78: 1277-1278 [PMID: 5426134]
2. Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer 1985; 56: 840-848 [PMID: 2410093 DOI: 10.1002/1097-0142.]
3. Ishikura H, Kirimoto K, Shamoto M, Miyamoto Y, Yamagiwa H, Itoh T, Aizawa M. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 1986; 58: 119-126 [PMID: 2423220]
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051 DOI: 10.1002/hep.20933]
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430 [PMID: 11592607 DOI: 10.1016/ S0168-8278(01)00130-1]
6. Kumashiro Y, Yao T, Aishima S, Hirahashi M, Nishiyama K, Yamada T, Takayanagi R, Tsuneyoshi M. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol 2007; 38: 857-863 [PMID: 17320150 DOI: 10.1016/ j.humpath.2006.10.020]
7. Gakiopoulou H, Givalos N, Liapis G, Agrogiannis G, Patsouris E, Delladetsima I. Hepatoid adenocarcinoma of the gallbladder. Dig Dis Sci 2007; 52: 3358-3362 [PMID: 17510803 DOI: 10.1007/s10620-007-9807-3]
8. Liu Q, Bannan M, Melamed J, Witkin GB, Nonaka D. Two cases of hepatoid adenocarcinoma of the intestine in association with inflammatory bowel disease. Histopathology 2007; 51: 123-125 [PMID: 17532770 DOI: 10.1111/ j.1365-2559.2007.02715.x]
9. Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer 2002; 38: 211-214 [PMID: 12399135 DOI: 10.1016/ S0169-5002(02)00214-3]
10. Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch 2003; 442: 381-387 [PMID: 12715173]
11. Sano T, Izuishi K, Takebayashi R, Akamoto S, Kakinoki K, Okano K, Masaki T, Suzuki Y. Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity. Hepatogastroenterology 2011; 58: 2067-2070 [PMID: 22024077 DOI: 10.5754/hge11188]
12. Metzgeroth G, Ströbel P, Baumbusch T, Reiter A, Hastka J. Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity. Onkologie 2010; 33: 263-269 [PMID: 20502062 DOI: 10.1159/000305717]
13. Nagai E, Ueyama T, Yao T, Tsuneyoshi M. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 1993; 72: 1827-1835 [PMID: 7689918 DOI: 10.1002/1097-0142]
14. Liu X, Cheng Y, Sheng W, Lu H, Xu X, Xu Y, Long Z, Zhu H, Wang Y. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol 2010; 34: 1465-1471 [PMID: 20871221 DOI: 10.1097/PAS.0b013e3181f0a873]
15. Inagawa S, Shimazaki J, Hori M, Yoshimi F, Adachi S, Kawamoto T, Fukao K, Itabashi M. Hepatoid adenocarcinoma of the stomach. Gastric Cancer 2001; 4: 43-52 [PMID: 11706627 DOI: 10.1007/s101200100016]
16. Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Sur Pathol 2003; 27: 1302-1312 [PMID: 14508391 DOI: 10.1097/00000478-200310000-00002]
17. Caruso RA, Basile F, Fedele F, Zuccalà V, Crisafulli C, Fracassi MG, Quattrocchi E, Venuti A, Fabiano V. Gastric hepatoid adenocarcinoma with autophagy-related necrosis-like tumor cell death: report of a case. Ultrastruct Pathol 2006; 30: 301-307 [PMID: 16971355 DOI: 10.1080/01913120600820575.]
18. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
19. Kodama T, Kameya T, Hirota T, Shimosato Y, Ohkura H, Mukojima T, Kitaoka H. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer 1981; 48: 1647-165 [PMID: 6169423]
20. Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 2011; 17: 4563-4571 [PMID: 22147961 DOI: 10.3748/wjg. v17.i41.4563]
21. Hammad A, Jasnosz KM, Olson PR. Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature. Arch Pathol Lab Med 1995; 119: 1075-1079 [PMID: 7487411]
22. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003; 16: 137-144 [PMID: 12591966 DOI: 10.1097/01.MP.0000052103.13730.20]
23. Porcell AI, De Young BR, Proca DM, Frankel WL. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Pathol 2000; 13: 773-77 [PMID: 10912937 DOI: 10.1038/modpathol.3880134]
24. Naghibalhossaini F, Ebadi P. Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme. Cancer Lett 2006; 234: 158-16 [PMID: 15893415 DOI: 10.1016/j.canlet.2005.03.028]
25. Bombski G, Gasiorowska A, Orszulak-Michalak D, Neneman B, Kotynia J, Strzelczyk J, Janiak A, Malecka-Panas E. Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. Int J Colorectal Dis 2003; 18: 148-152 [PMID: 12548418]
26. Pectasides D, Mylonakis A, Kostopoulou M, Papadopoulou M, Triantafillis D, Varthalitis J, Dimitriades M, Athanassiou A. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 1997; 20: 348-353 [PMID: 9256887 DOI: 10.1097/00000421-199708000-00005]
27. Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD, Vickers SM, Langmead CJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE. Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res 2011; 17: 805-816 [PMID: 21325298 DOI: 10.1158/1078-0432.CCR-10-0248]
28. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-972 [PMID: 11007036 DOI: 10.1038/ modpathol.3880175]
29. Sentani K, Oue N, Sakamoto N, Arihiro K, Aoyagi K, Sasaki H, Yasui W. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach. Mod Pathol 2008; 21: 464-475 [PMID: 18204429 DOI: 10.1038/modpathol.3801050]
30. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, Hippo Y, Kodama T, Iwanari H, Aburatani H, Fukayama M. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005; 18: 1591-1598 [PMID: 15920546 DOI: 10.1038/modpathol. 3800436]
31. Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 2003; 119: 361-366 [PMID: 12645337 DOI: 10.1309/8L872RPHEJRKF5JJ]
32. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol 2004; 122: 721-72 [PMID: 15491968 DOI: 10.1309/KC09YTF2M4DLUYQ6]
33. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003; 16: 403-410 [PMID: 12748245 DOI: 10.1097/01.MP.0000067683.84284.66]
34. Lau SK, Prakash S, Geller SA, Alsabeh R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002; 33: 1175-1181 [PMID: 12514785 DOI: 10.1053/ hupa.2002.130104]
35. Hishinuma M, Ohashi KI, Yamauchi N, Kashima T, Uozaki H, Ota S, Kodama T, Aburatani H, Fukayama M. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma. Histopathology 2006; 49: 479-486 [PMID: 17064293 DOI: 10.1111/ j.1365-2559.2006.02522.x]
36. Kim MA, Lee HS, Yang HK, Kim WH. Cytokeratin expression profile in gastric carcinomas. Hum Pathol 2004; 35: 576-581 [PMID: 15138932 DOI: 10.1016/j.humpath.2003.12.007]